Skip to main content
. 2015 Jun 17;2(3):81–88. doi: 10.1530/ERP-14-0084

Table 1.

Clinical data of both cohorts.

Clinical data Group 1 (n=25) Group 2 (n=25) P
Age 45±12 63±15 0.37
Male 16 (64%) 11 (44%) 0.13
Female 9 (36%) 14 (56%) 0.13
Smoker 6 (24%) 7 (28%) 0.71
Alcohol consumption 0 (0%) 0 (0%) NS
Arterial hypertension 5 (20%) 11 (44%) 0.41
Coronary heart disease 0 (0%) 2 (8%) 0.15
Pulmonary embolism 0 (0%) 1 (4%) 0.31
Diabetes mellitus type 2 0 (0%) 5 (20%) 0.16
Peripheral arterial disease 0 (0%) 2 (8%) 0.15
Hypercholesterinemia 0 (0%) 2 (8%) 0.15
Chronic obstructive pulmonary disease 0 (0%) 4 (16%) 0.34
β-blocker therapy 10 (0%) 7 (28%) 0.29
Ace-inhibitor therapy 11 (0%) 5 (20%) 0.29
Calcium antagonist therapy 0 (0%) 2 (8%) 0.15